Dr. Phioanh (Leia) Nghiemphu, MD

Claim this profile

UCLA Medical Center

Studies Neurofibromatosis
Studies Neurofibroma
2 reported clinical trials
3 drugs studied

Area of expertise

1Neurofibromatosis
Phioanh (Leia) Nghiemphu, MD has run 2 trials for Neurofibromatosis. Some of their research focus areas include:
NF2 positive
NF1 positive
2Neurofibroma
Phioanh (Leia) Nghiemphu, MD has run 2 trials for Neurofibroma. Some of their research focus areas include:
NF2 positive
NF1 positive

Affiliated Hospitals

Image of trial facility.
UCLA Medical Center
Image of trial facility.
UCLA Oncology Center

Clinical Trials Phioanh (Leia) Nghiemphu, MD is currently running

Image of trial facility.

Targeted Therapy

for Neurofibromatosis

This is a multi-arm phase II platform-basket screening study designed to test multiple experimental therapies simultaneously in patients with NF2-related schwannomatosis (NF2-SWN, formerly known as neurofibromatosis type 2) with associated progressive tumors of vestibular schwannomas (VS), non-vestibular schwannomas (non-VS), meningiomas, and ependymomas. This Master Study is being conducted as a "basket" study that may allow people with multiple tumor types associated with NF2-SWN to receive new drugs throughout this study. Embedded within the Master Study are individual drug substudies. * Investigational Drug Sub-study A: Brigatinib * Investigational Drug Sub-study B: Neratinib
Recruiting1 award Phase 218 criteria

More about Phioanh (Leia) Nghiemphu, MD

Clinical Trial Related4 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 1 Active Clinical Trial
Treatments Phioanh (Leia) Nghiemphu, MD has experience with
  • Brigatinib
  • Neratinib
  • Mirdametinib (PD-0325901)
Breakdown of trials Phioanh (Leia) Nghiemphu, MD has run
Neurofibromatosis
Neurofibroma
Acoustic Neuroma
Ependymoma
Meningioma

Other Doctors you might be interested in

Peyman Benharash, MDUCLA Medical Center
Edward Lee, MDUniversity of California Los Angeles - Ronald Reagan Medical Center
Marcella Press, MDUCLA Medical Center

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Phioanh (Leia) Nghiemphu, MD specialize in?
Phioanh (Leia) Nghiemphu, MD focuses on Neurofibromatosis and Neurofibroma. In particular, much of their work with Neurofibromatosis has involved NF2 positive patients, or patients who are NF1 positive.
Is Phioanh (Leia) Nghiemphu, MD currently recruiting for clinical trials?
Yes, Phioanh (Leia) Nghiemphu, MD is currently recruiting for 1 clinical trial in Los Angeles California. If you're interested in participating, you should apply.
Are there any treatments that Phioanh (Leia) Nghiemphu, MD has studied deeply?
Yes, Phioanh (Leia) Nghiemphu, MD has studied treatments such as Brigatinib, Neratinib, Mirdametinib (PD-0325901).
What is the best way to schedule an appointment with Phioanh (Leia) Nghiemphu, MD?
Apply for one of the trials that Phioanh (Leia) Nghiemphu, MD is conducting.
What is the office address of Phioanh (Leia) Nghiemphu, MD?
The office of Phioanh (Leia) Nghiemphu, MD is located at: UCLA Medical Center, Los Angeles, California 90095 United States. This is the address for their practice at the UCLA Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top